Linghang Wang
Impact in
- Infectious Diseases top 2%
- SARS-CoV-2 and COVID-19 Research
- SARS-CoV-2 detection and testing
- COVID-19 Clinical Research Studies
- Viral gastroenteritis research and epidemiology
Papers in
-
- COVID-19 Clinical Research Studies 10
- SARS-CoV-2 and COVID-19 Research 9
- SARS-CoV-2 detection and testing 8
- Virology 5
- HIV Research and Treatment 5
Linghang Wang
36 papers receiving 1.1k citations
Hit Papers
Peers
Comparison fields: 5 of 115
- Infectious Diseases 686
- Applied Microbiology and Biotechnology 25
- Modeling and Simulation 50
- Hepatology 74
- General Dentistry 13
Countries citing papers authored by Linghang Wang
This map shows the geographic impact of Linghang Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Linghang Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Linghang Wang more than expected).
Fields of papers citing papers by Linghang Wang
This network shows the impact of papers produced by Linghang Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Linghang Wang. The network helps show where Linghang Wang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Linghang Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 12 | |
| 3 | 2024 | 0 | |
| 4 | 2023 | 6 | |
| 5 | 2023 | 5 | |
| 6 | Drug Resistance to HIV-1 Integrase Inhibitors Among Treatment-Naive Patients in Beijing, China | 2022 | 15 |
| 7 | 2022 | 3 | |
| 8 | 2022 | 4 | |
| 9 | 2021 | 7 | |
| 10 | 2021 | 70 | |
| 11 | 2021 | 8 | |
| 12 | 2020 | 11 | |
| 13 | 2020 | 2 | |
| 14 | 2020 | 11 | |
| 15 | 2019 | 1 | |
| 16 | 2018 | 6 | |
| 17 | 2016 | 2 | |
| 18 | 2013 | 48 | |
| 19 | Clinical analysis of 61 AIDS patients complicated with central nervous system disorders | 2010 | 1 |
| 20 | 2003 | 80 |
About Linghang Wang
Linghang Wang is a scholar working on Infectious Diseases, Virology, Small Animals, Applied Microbiology and Biotechnology and Modeling and Simulation, having authored 40 papers that have together received 1.1k indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (10 papers), SARS-CoV-2 and COVID-19 Research (9 papers), SARS-CoV-2 detection and testing (8 papers), HIV Research and Treatment (5 papers), Brucella: diagnosis, epidemiology, treatment (5 papers), Atherosclerosis and Cardiovascular Diseases (4 papers), Galectins and Cancer Biology (4 papers) and Respiratory viral infections research (3 papers). The work is most often cited by research in Infectious Diseases (686 citations), Applied Microbiology and Biotechnology (25 citations), Modeling and Simulation (50 citations), Hepatology (74 citations) and General Dentistry (13 citations). Linghang Wang has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Siyuan Yang, Yunxia Tang, Fengting Yu, Fujie Zhang, Guiju Gao, Chengjie Ma, Liting Yan, Yong Guo, Chianru Tan and Nan Wang. Their work appears in journals such as BMC Infectious Diseases, China CDC Weekly, PLoS ONE, Infection and Drug Resistance and The Innovation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.